SCHEMBL25440308

SCHEMBL25440308

CSc1ccc(N(c2ccc(SC)cc2)C(C(=O)OC(C)C)C(=O)OC(C)C)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOX1 Q9Y5S8 1/20 0.40
AKR1C3 P42330 3/20 0.36
AKR1C2 P52895 3/20 0.36
ACACB O00763 1/20 0.36
PLK1 P53350 1/20 0.35
SLC6A4 P31645 3/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MAPT P10636 1/20 0.35
RCE1 Q9Y256 1/20 0.35
MMP1 P03956 1/20 0.34
MMP2 P08253 1/20 0.34
MMP3 P08254 1/20 0.34
MMP9 P14780 1/20 0.34
MMP8 P22894 1/20 0.34
MMP13 P45452 1/20 0.34
MMP14 P50281 1/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25440240 0.94 KMT2A (0.40) NOX1AKR1C3AKR1C2MEN1KMT2A
SCHEMBL25439936 0.81 ALOX5 (0.42) ALDH1A1KDM4ETDP1L3MBTL1LMNA
SCHEMBL25440185 0.80 MEN1 (0.46) MEN1KMT2AALDH1A1MAPTTDP1
SCHEMBL26324996 0.80 ALDH1A1 (0.37) NOX1AKR1C3AKR1C2ACACBMEN1
SCHEMBL25440144 0.80 TSHR (0.44) KMT2AALDH1A1KDM4EMAPTTDP1
SCHEMBL26327948 0.78 TAS1R3 (0.39) NOX1SLC6A4MEN1KMT2AALDH1A1
SCHEMBL25440154 0.77 PDCD1 (0.54) MAPTMMP2MMP3MMP9MMP8
SCHEMBL25439854 0.76 PDCD1 (0.53) KMT2AALDH1A1MAPTMMP2MMP3
SCHEMBL25439798 0.76 TRPM8 (0.40) MEN1KMT2AALDH1A1MAPTTDP1
SCHEMBL25439886 0.75 ALOX5 (0.45) ACACBMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents WILLIAM MARSH RICE UNIVERSITY (US) 2023-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents PNMT, NCL, NPM1 NOX1 3816/4885AKR1C3 3707/4885AKR1C2 3371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.